ClinicalTrials.Veeva

Menu

Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

S

Sohag University

Status

Enrolling

Conditions

Diabetic Polyneuropathy

Study type

Observational

Funder types

Other

Identifiers

NCT06514846
Soh-Med-24-06-01MS

Details and patient eligibility

About

The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.

Enrollment

100 estimated patients

Sex

All

Ages

33 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ü Age: 30-55 y

ü Type of diabetes: Type 2

ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria

Exclusion criteria

  • Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.

Trial design

100 participants in 1 patient group

Patients Group
Description:
Study Population: Place of study: Participants will be recruited from the diabetes clinic, Sohag university hospital. Type of the study: Cross-Sectional Comparative study. Patients: v Study group: participants of the study will meet the following criteria: Ø Inclusion criteria: ü Age: 30-55 y ü Type of diabetes: Type 2 ü Duration of diabetes: Within 1 Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria ü Gender: Both males \& females Ø Exclusion criteria: Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.

Trial contacts and locations

1

Loading...

Central trial contact

Reda Khalaf Allah Khalil, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems